Effects of allopurinol, a xanthine oxidise inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats

Blood Pressure

Volumn 14, Issue 2, 2005, Pages 120-125

  Minami, Mayumi ^a   Ishiyama, Akihiro ^c   Takagi, Masao ^c   Omata, Masao ^b   Atarashi, Keiichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO METROPOLITAN POLICE HOSPITAL   (Japan)

Author keywords

Hypercholesterolemia induced hypertension; Lipid peroxidation; Xanthine oxidase inhibitor

Indexed keywords

ALLOPURINOL; CHOLESTEROL; IRON; LIPID; LIPID PEROXIDE; MALONALDEHYDE; NITRATE; PROTEIN; URIC ACID; XANTHINE OXIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY INJURY; LIPID BLOOD LEVEL; LIPID DIET; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RAT STRAIN; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; URINARY EXCRETION;

ALLOPURINOL; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; CREATININE; ENZYME INHIBITORS; HEART RATE; HEMODYNAMIC PROCESSES; HYPERCHOLESTEROLEMIA; HYPERTENSION; IRON; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MALONDIALDEHYDE; NITRIC OXIDE; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES; URIC ACID; XANTHINE OXIDASE;

EID: 18444396626     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050510008878     Document Type: Article

References (32)

1. Laurenzi M, Mancini M, Menotti A, Stamler R, Trevisan M, Zanchetti A, on behalf of the Gubbio Study Group. Multiple risk factors in hypertension: Results from the Gubbio Study. J Hypertens. 1990;8 Supple 1:S7-S12.
2. Minami M, Atarashi K, Ishiyama A, Hirata Y, Goto A, Omata M. Pressor hyperreactivity to mental and hand-grip stresses in patients with hypercholesterolemia. J Hypertens. 1999;17:185-192.
3. Ishiyama A, Atarashi K, Minami M, Takagi M, Kimura K, Goto A, et al. Role of free radicals in the pathogenesis of lipid-induced glomerulosclerosis in rats. Kidney Int. 1999; 55:1348-1358.
4. Atarashi K, Takagi M, Minami M, Ishiyama A. Effects of alacepril and amlodipine on the renal injury induced by a high-cholesterol diet in rats. J Hypertens. 1999; 17:1983-1986.
5. Atarashi K, Ishiyama A, Minami M, Takagi M, Omata M. Effects of acute hypercholesterolemia on blood pressure and pressor response to norepinephrine in rats. Blood Press. 2004;13:56-61.
6. Friedl HP, Till GO, Ryan US, Ward PA. Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J. 1989;3:2512-2518.
7. Bulkey GB. Reactive oxygen metabolites and reperfusion injury: Aberrant triggering of reticuloendothelial function. Lancet. 1994;344:934-936.
8. McKelvey G, Hollwarth E, Glanger N, Engerson, Landler U, Jones P. Mechanisms of conversion of xanthine dehydrogenase to xanthine oxidase in ibchemic rat liver and kidney. Am J Physiol. 1988;27:G753-G760.
9. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci USA. 1981;78:6858-6862.
10. Cardillo C, Kilcoyne CM, Cannon RO III, Quyyumi AA, Panza JA. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension. 1997;30 [part 1]:57-63.
11. Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, et al. Effects of xanthine oxidase inhibition with allopurinol on endotherial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: Results from 2 placebo-controlled studies. Circulation. 2002;105:2619-2624.
12. Yagi K. Micro-determination of lipoperoxide in blood plasma or serum. Vitamines (Japan). 1975;49:403-405.
13. 15N] nitrate in biological fluids. Anal Biochem. 1982;126:131-138.
14. Liang L, D'Haese PC, Lamberts LV, De Broe ME. Direct determination of iron in urine and serum using graphite furnace atomic absorption spectrometry. Analyst. 1989; 114:143-147.
15. Kimura K, Drozdova G, Hirata Y, Matsuoka H, Ishii M, Sugimoto T, et al. Effect of chronic administration of atrial natriuretic polypeptide on glomerular lesions in spontaneously hypertensive rats. Jpn Heart J. 1990;31:227-236.
16. Goode GK, Miller J, Haegerty AM. Hyperlipidemia, hypertension, and coronary diseases. Lancet. 1995;345:362-364.
17. Spósito AC, Mansur AP, Coelho OR, Nicolau JC, Ramires JAF. Additional reduction in blood pressure after cholesterol-lowering treatment by statin (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril). Am J Cardiol. 1999;83:1497-1499.
18. Minami M, Atarashi K, Ishiyama A, Hirata Y, Goto A, Omata M. Effects of cholesterol-lowering therapy on pressor hyperreactivity to stress in hypercholesterolemic patients. Hypertens Res. 2003;26:273-280.
19. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993;91:2546-2451.
20. Warnholtz A, Nickenig G, Schulz E, Macharzina R, Brasen JH, Skatchkov M, et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system. Circulation. 1999;99:2027-2033.
21. Ohara Y, Peterson TE, Sayegh HS, Subramanian RR, Wilcox JN, Harrison DG. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation. 1995;92:898-903.
22. Chowienczyk PJ, Watts GF, Cockroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolemia. Lancet. 1992; 340:1430-1432.
23. Mügge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res. 1991;69:1293-1300.
24. Guzik TJ, West NEJ, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM. Vascular superoxide production by NAD(P)H oxidase: Association with endothelial dysfunction and clinical risk factors. Circ Res. 2000;86:1008.
25. Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int. 1988;34:474-480.
26. Lopez-Neblina F, Toledo-Pereyra LH, Suzuki S, Mirmiran R. Protective effect of combined allopurinol and verapamil given at reperfusion in severe renal ischemia. J Invest Surg. 1995;8:57-63.
27. Hiraishi H, Terano A, Razandi M, Pedram A, Sugimoto T, Harada T, et al. Reactive oxygen metabolite-induced toxicity to cultured bovine endothelial cells: Status of cellular iron in mediating injury. J Cell Physiol. 1994;160:132-134.
28. White CR, Darley-Usmar V, Berrington WR, McAdams M, Gore JZ, Thompson JA, et al. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA. 1996; 93:8745-8749.
29. Butler R, Morris AD, Belch JJF, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension. 2003; 35:746-751.
30. Minor RL Lr, Myers PR, Guerra R Jr, Bates JN, Harrison DD. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1994;124:2109-2116.
31. Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ, Maxwell SR. Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci. 2003;105:425-430.
32. Nieto FJ, Irubarren C, Gross MD, Comstock GW, Cutlur RG. Uric acid and serum antioxidant capacity; A reaction to atherosclerosis? Atherosclerosis. 2000; 148:131-139.